Showing results (1441-1450 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|May 16, 2018
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FCTimothy F Cloughesy, Joseph Landolfi, Michael A Vogelbaum, et al.
Neuro-Oncology|May 3, 2018
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1Andrea M Gross, Gurbani Singh, Srivandana Akshintala, et al.
Neuro-Oncology|April 19, 2019
Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patientsJeffrey P Gross, Stephanie Powell, Frank Zelko, et al.
Neuro-Oncology|August 21, 2018
Sex-specific gene and pathway modeling of inherited glioma riskQuinn T Ostrom, Warren Coleman, William Huang, et al.
Neuro-Oncology|October 16, 2012
The effects of radiotherapy on psychosocial and cognitive functioning in adults with a primary brain tumor: a prospective evaluationMaria Kangas, Robyn L Tate, Janet R Williams, et al.
Neuro-Oncology|October 18, 2012
Expression of αB-crystallin overrides the anti-apoptotic activity of XIAPJee Suk Lee, Hye Young Kim, Na Young Jeong, et al.
Neuro-Oncology|October 18, 2012
Function of carbonic anhydrase IX in glioblastoma multiformeMartin A Proescholdt, Marsha J Merrill, Eva-Maria Stoerr, et al.
Neuro-Oncology|October 19, 2012
Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysisPiergiorgio Modena, Francesca R Buttarelli, Rosalba Miceli, et al.
Neuro-Oncology|August 18, 2012
Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence dataFaith G Davis, Therese A Dolecek, Bridget J McCarthy, et al.
Neuro-Oncology|November 17, 2022
RAGE ablation attenuates glioma progression and enhances tumor immune responses by suppressing galectin-3 expressionIan Y Zhang, Shunan Liu, Leying Zhang, et al.
Pageof 316